Effect of long-term trimethoprim-sulfamethoxazole prophylaxis on ascites formation, bacterial translocation, spontaneous bacterial peritonitis, and survival in cirrhotic rats

Digestive Diseases and Sciences

Volumn 44, Issue 10, 1999, Pages 1957-1962

  Guarner, Carlos ^a   Runyon, Bruce A ^a,b   Heck, Mary ^a   Young, Sharon ^a   Sheikh, Muhammad Y ^a  

^a University of Louisville School of Medicine   (United States)

^b LOMA LINDA UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

Ascites; Cirrhosis; Prophylaxis; Spontaneous bacterial peritonitis; Trimethoprim sulfamethoxazole

Indexed keywords

CARBON TETRACHLORIDE; COTRIMOXAZOLE; NORFLOXACIN;

ANIMAL MODEL; ANTIBIOTIC PROPHYLAXIS; ARTICLE; ASCITES; BACTERIAL PERITONITIS; BACTERIAL TRANSLOCATION; CONTROLLED STUDY; DOSE TIME EFFECT RELATION; EXPERIMENTAL LIVER CIRRHOSIS; GRAM NEGATIVE BACTERIUM; INCIDENCE; INTESTINE FLORA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; SURVIVAL RATE; SURVIVAL TIME;

ANIMALS; ANTI-INFECTIVE AGENTS; ANTIBIOTIC PROPHYLAXIS; ASCITES; BACTERIAL TRANSLOCATION; CARBON TETRACHLORIDE POISONING; GRAM-NEGATIVE BACTERIAL INFECTIONS; LIVER CIRRHOSIS, EXPERIMENTAL; MALE; PERITONITIS; RATS; RATS, SPRAGUE-DAWLEY; TRIMETHOPRIM-SULFAMETHOXAZOLE COMBINATION;

EID: 0032710798     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1026649730012     Document Type: Article

References (26)

1. Soriano G, Guarner C, Tomas A, Villanueva C, Torras X, Gonzalez D, Sainz S, Anguera A, Cusso X, Balanzo J, Vilardell F: Norfloxacin prevents bacterial infection in cirrhotics with gastrointestinal bleeding. Gastroenterology 103:1267-1272, 1992
2. Soriano G, Guarner C, Teixido M, Such J, Barrios J, Enriquez J, Vilardell F: Selective intestinal decontamination prevents spontaneous bacterial peritonitis. Gastroenterology 100:477- 481, 1991
3. Novella MT, Solá R, Soriano G, Andreu M, Gana J, Ortiz J, Coll S, Sàbat M, Vila MC, Guarner C, Vilardell F: Continuous vs inpatient prophylaxis of the first episode of spontaneous bacterial peritonitis with norfloxacin. Hepatology 25:532-536, 1997
4. Ginés P, Rimola A, Planas R, Vargas V, Marco F, Almela M, Forna M, Miranda ML, LLach J, Salmerón JM, Rodés J: Norfloxacin prevents spontaneous bacterial peritonitis recurrence in cirrhosis: Results of a double-blind, placebo- controlled trial. Hepatology 12:716-724, 1990
5. Runyon BA, Borzio M, Young S, Squier SU, Guarner C, Runyon M: Effect of selective bowel decontamination with norfloxacin on spontaneous bacterial peritonitis, translocation, and survival in an animal model of cirrhosis. Hepatology 21:1719-1724, 1995
6. Ortiz J, Soriano G, Sola R, Gana J, Novella MT, Coll S, Sabal M, Vila MC, Andreu M, Guarner C, Vilardell F: Characteristics of the infections caused by Escherichia coli resistant to norfloxacin in hospitalized cirrhotic patients. Hepatology 22:166A, 1995
7. Llovet JM, Rodriguez-Iglesias P, Moitinho E, Planas R, Bataller R, Navasa M, Menacho M, Pardo A, Castells A, Cabré E, Arroyo V, Gassull MA, Rodés J: Spontaneous bacterial peritonitis in patients with cirrhosis undergoing selective intestinal decontamination. J Hepatol 26:88-95, 1997
8. Singh N, Gayowski T, Yu VL, Wagener MM: Trimethoprim- sulfamethoxazole for the prevention of spontaneous bacterial peritonitis in cirrhosis: A randomized trial. Ann Intern Med 122:595-598, 1995
9. Runyon BA, Sugano S, Kanel G, Mellencamp MA: A rodent model of cirrhosis, ascites and bacterial peritonitis. Gastroenterology 100:489-493, 1991
10. Runyon BA, Squier S, Borzio M: Translocation of gut bacteria in rats with cirrhosis to mesenteric lymph nodes partially explains the pathogenesis of spontaneous bacterial peritonitis. J Hepatol 21:792-796, 1994
11. Gautreaux MD, Deitch LA, Berg RD: Bacterial translocation from the gastrointestinal tract to various segments of the mesenteric lymph node complex. Infect Immun 62:2132-2134, 1994
12. Garcia-Tsao G, Lee F-Y, Barden GE, Cartun R, West AB: Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology 108:1835-1841, 1995
13. Lew MA, Kehoc K, Ritz J, Antman KH, Nadler L, Kalish LA, Finberg R: Ciprofloxacin versus trimethoprim/sulfamethoxazole for prophylaxis of bacterial infections in bone marrow transplant recipients: A randomized, controlled trial. J Clin Oncol 13:239-250, 1995
14. Keiser P, Higgs E, Smith J: Neutropenia is associated with bacteremia in patients infected with the human immunodeficiency virus. Am J Med Sci 312:118-122, 1996
15. Guarner C, Runyon BA, Young S, Heck M, Seikh MY: Intestinal bacterial overgrowth and bacterial translocation in an experimental model of cirrhosis in rats with ascites. J Hepatol 26:1372-1378, 1997
16. Llovet JM, Bartoli R, Planas R, Cabre E, Jimenez M, Urban A, Ojanguren I, Arnal J, Gassull MA: Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis. Gut 35:1648-1652, 1994
17. Emmanouilides CE, Lianou PE, Bassaris HP, Papavassiliou JT: Trimethoprim, sulphamethoxazole, bacterial adhesion and polymorphonuclear leukocyte funetion. J Antimicrob Chem 26:803-812, 1990
18. De Man P, Jodal U, Lincoln K, Svanborg-Edén C: Bacterial attachment and inflammation in the urinary tract. J Infect Dis 158:29-35, 1988
19. Leach BE, Forbes JC: Sulfonamide drugs as protective agents against carbon tetrachloride poisoning. Proc Soc Exp Biol Med 48:361-363, 1941
20. Nolan JP: Intestinal endotoxins as mediators of hepatic injury. An idea whose time has come again. Hepatology 10:887-891, 1989
21. Nolan JP, Leibowitz AI: Modification of acute carbon tetrachloride injury by polymyxin B - an antidendotoxin. Gastroenterology 75:445-449, 1978
22. Danni O, Chiarpotto E, Aragno M, Biasi F, Cornoglio A, Belliardo F, Dianzani MU, Poli G: Toxicol Appl Pharmacol 110:216-222, 1991
23. Varela-Moreiras G, Alonso-Aperte E, Rubio M, Gassó M, Deulofeu R, Alvarez L, Caballeria J, Rodés J, Mato JM: Carbon tetrachloride-induced hepatic injury is associated with global DNA hypomethylation and homocysteinemia: Effect of S-adenosylmethionine treatment. Hepatology 22:1310-1315, 1995
24. Manna Z, Guopei S, Minuk GY: Effects of hepatic stimulator substance, herbal medicine, selenium/vitamin E, and ciprofloxacin on cirrhosis in the rat. Gastroenterology 110:1150- 1153, 1996
25. Roberts DE, Curd JG: Sulfonamides as antiinflammatory agents in the treatment of Wegener's granulomatosis. Arthritis Rheum 33:1590-1593, 1990
26. Stegeman CA, Cohen Tervaert JW, De Jong PE, Kallenberg CGM: Trimethoprim-sulfamethoxazole (co-trimoxazole) for the prevention of relapses of Wegener's granulomatosis. N Engl J Med 335:16-20, 1996